Universitätsklinikum Jena

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms (2026) Thurner L, Fadle N, Thurner B, Kos IA, Bewarder M, Regitz E, Bette B, et al. Journal article Between guidelines and reality: expert neurologists’ perspectives on structural resources for ALS care in Germany (2026) Linse K, Lulé D, Schöberl F, Reilich P, Ilse B, Metelmann M, Eickhoff C, et al. Journal article Celastrol attenuates Th1- and Th2-driven skin inflammation in 2D and 3D in vitro models (2026) Reddersen K, Morgner B, Werz O, Lorkowski S, Fischer D, Tittelbach J, Wiegand C Journal article Variations in surgical strategies and treatment allocation for retroperitoneal sarcomas across German-speaking sarcoma centres (2026) Albertsmeier M, Tiefes A, Tirotta F, Bauer A, Lindner LH, Di Gioia D, Schmidt-Hegemann NS, et al. Journal article SAHA-coupled biocompatible cellulose-based nanoparticles as HDAC-inhibitory drug delivery systems with slow and sustained release behavior (2026) Skodda LH, Nußpicker M, Lins A, Hofstetter RK, Klement L, Graßl V, Westhoff J, et al. Journal article Health-Related Quality of Life in Children with X-Linked Hypophosphatemia Treated with Burosumab: Real-World Data from a German-Swiss Study (2026) Böckmann I, Klein M, Mutze H, Rehberg M, Spartà G, Evers K, Schlingmann KP, et al. Journal article Development and analysis of a SmPC-based machine-readable dataset of contraindications for clinical decision support and real-world data analysis (2026) Schechner M, Andrikyan W, Bauerdick T, Terstegen T, Redeker L, Federbusch M, Farker K, et al. Journal article An international multicenter cohort study of management and outcomes of undescended testis in German-speaking countries (2026) Aubert O, Föller J, Beume JS, Brinkmann O, Degener S, Drießler C, Eckoldt F, et al. Journal article Papillary renal cell carcinoma – exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review (2026) Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, et al. Journal article Nivolumab in combination with lenvatinib in unresectable hepatocellular carcinoma: The IKF-t006/IMMUNIB translational phase-2 study (2026) Vogel A, Ben Khaled N, Ramirez JR, Marhenke S, Siegler G, Siebler J, Lindig U, et al. Journal article